Something I didn’t expect to see during my career: Severe acute and chronic Graft-versus host disease <6% in well-matched myeloablative transplantation. One death due to GVHD out of 125 patients, and that was too many. It’s undeniably a new era in Bone Marrow Transplant.
Source: Shernan Holtan /Twitter